WHO Urges Scale up of Newborn Screening to Improve Early Detection and Care of Birth Defects

Why It Matters

Early detection and treatment of birth defects can dramatically cut child mortality and lifelong disability, directly supporting universal health coverage goals and the Sustainable Development Goals in regions where the need is greatest.

Key Takeaways

• 8 million newborns worldwide have birth defects each year
• Birth defects cause ~8% of under‑five deaths globally
• 90% of severe cases occur in low‑ and middle‑income countries
• India screened 28 million infants, identifying 900 k with defects
• WHO recommends starting screening with one priority condition, then expand

Pulse Analysis

The WHO’s new report shines a spotlight on a silent pandemic: birth defects that affect millions of newborns and now represent a growing share of under‑five mortality. While infectious diseases have receded, the proportion of child deaths linked to congenital conditions has risen from 1% to 4% in sub‑Saharan Africa and up to 11% in South Asia since 2000. Early identification of treatable conditions such as congenital hypothyroidism, sickle‑cell disease, hearing loss and metabolic disorders can prevent death and lifelong impairment, making newborn screening a high‑impact public‑health intervention.

Across diverse health systems, several countries have demonstrated that large‑scale screening is feasible and cost‑effective. Argentina and Brazil have moved toward universal coverage, while India’s three‑year programme screened over 28 million infants, linking 900 000 children to diagnosis and care. The Philippines integrated 29‑condition screening into a national insurance scheme, and Uganda’s targeted sickle‑cell program provides lifesaving treatment in high‑burden districts. These examples illustrate how political commitment, streamlined diagnostic pathways, and financing through universal health coverage can overcome traditional barriers in low‑resource settings.

For policymakers, the WHO’s call to action translates into concrete steps: prioritize one condition aligned with local disease burden, embed screening within existing maternal‑child health services, and invest in laboratory capacity and training. Scaling up will accelerate progress toward SDG 3, which aims to end preventable deaths of newborns and children under five. With strategic investment, the global community can ensure that no child’s future is compromised by a condition that could have been detected at birth.